Literature DB >> 19164571

Capsule of Cryptococcus neoformans grows by enlargement of polysaccharide molecules.

Susana Frases1, Bruno Pontes, Leonardo Nimrichter, Nathan B Viana, Marcio L Rodrigues, Arturo Casadevall.   

Abstract

The human pathogenic fungus Cryptococcus neoformans has a distinctive polysaccharide (PS) capsule that enlarges during infection. The capsule is essential for virulence, but the mechanism for capsular growth is unknown. In the present study, we used dynamic light scattering (LS) analysis of capsular PS and optical tweezers (OT) to explore the architecture of the capsule. Analysis of capsular PS from cells with small and large capsules by dynamic LS revealed a linear correlation between PS effective diameter and microscopic capsular diameter. This result implied that capsule growth was achieved by the addition of molecules with larger effective diameter, such that some molecules can span the entire diameter of the capsule. Measurement of polystyrene bead penetration of C. neoformans capsules by using OT techniques revealed that the outer regions were penetrable, but not the inner regions. Our results provide a mechanism for capsular enlargement based on the axial lengthening of PS molecules and suggest a model for the architecture of a eukaryotic microbial capsule.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19164571      PMCID: PMC2633523          DOI: 10.1073/pnas.0808995106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Cell wall alpha-1,3-glucan is required to anchor the Cryptococcus neoformans capsule.

Authors:  Amy J Reese; Tamara L Doering
Journal:  Mol Microbiol       Date:  2003-11       Impact factor: 3.501

2.  The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions.

Authors:  Oscar Zaragoza; Carlos P Taborda; Arturo Casadevall
Journal:  Eur J Immunol       Date:  2003-07       Impact factor: 5.532

3.  Cell-wall glucans of Cryptococcus neoformans Cap 67.

Authors:  P G James; R Cherniak; R G Jones; C A Stortz; E Reiss
Journal:  Carbohydr Res       Date:  1990-04-02       Impact factor: 2.104

4.  Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier.

Authors:  Caroline Charlier; Fabrice Chrétien; Marielle Baudrimont; Elodie Mordelet; Olivier Lortholary; Françoise Dromer
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

5.  Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity.

Authors:  S J Devi; R Schneerson; W Egan; T J Ulrich; D Bryla; J B Robbins; J E Bennett
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

6.  Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network.

Authors:  R Cherniak; H Valafar; L C Morris; F Valafar
Journal:  Clin Diagn Lab Immunol       Date:  1998-03

7.  Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations.

Authors:  Leonardo Nimrichter; Susana Frases; Leonardo P Cinelli; Nathan B Viana; Antonio Nakouzi; Luiz R Travassos; Arturo Casadevall; Marcio L Rodrigues
Journal:  Eukaryot Cell       Date:  2007-06-15

Review 8.  Cryptococcus neoformans capsule biosynthesis and regulation.

Authors:  Guilhem Janbon
Journal:  FEMS Yeast Res       Date:  2004-09       Impact factor: 2.796

9.  Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival.

Authors:  Oscar Zaragoza; Cara J Chrisman; Maria Victoria Castelli; Susana Frases; Manuel Cuenca-Estrella; Juan Luis Rodríguez-Tudela; Arturo Casadevall
Journal:  Cell Microbiol       Date:  2008-06-28       Impact factor: 3.715

10.  Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans.

Authors:  Diane C McFadden; Bettina C Fries; Fang Wang; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2007-06-29
View more
  54 in total

1.  Neurovirulence of Cryptococcus neoformans determined by time course of capsule accumulation and total volume of capsule in the brain.

Authors:  A Pool; L Lowder; Y Wu; K Forrester; J Rumbaugh
Journal:  J Neurovirol       Date:  2013-06-04       Impact factor: 2.643

2.  Macrophage mitochondrial and stress response to ingestion of Cryptococcus neoformans.

Authors:  Carolina Coelho; Ana Camila Oliveira Souza; Lorena da Silveira Derengowski; Carlos de Leon-Rodriguez; Bo Wang; Rosiris Leon-Rivera; Anamelia Lorenzetti Bocca; Teresa Gonçalves; Arturo Casadevall
Journal:  J Immunol       Date:  2015-02-02       Impact factor: 5.422

Review 3.  Emerging themes in cryptococcal capsule synthesis.

Authors:  Pardeep Kumar; Meng Yang; Brian C Haynes; Michael L Skowyra; Tamara L Doering
Journal:  Curr Opin Struct Biol       Date:  2011-09-01       Impact factor: 6.809

Review 4.  Variability of phenotypic traits in Cryptococcus varieties and species and the resulting implications for pathogenesis.

Authors:  Gunjan Gupta; Bettina C Fries
Journal:  Future Microbiol       Date:  2010-05       Impact factor: 3.165

5.  Exploring Cryptococcus neoformans capsule structure and assembly with a hydroxylamine-armed fluorescent probe.

Authors:  Conor J Crawford; Radamés J B Cordero; Lorenzo Guazzelli; Maggie P Wear; Anthony Bowen; Stefan Oscarson; Arturo Casadevall
Journal:  J Biol Chem       Date:  2020-01-31       Impact factor: 5.157

6.  Evidence for branching in cryptococcal capsular polysaccharides and consequences on its biological activity.

Authors:  Radames J B Cordero; Susana Frases; Allan J Guimaräes; Johanna Rivera; Arturo Casadevall
Journal:  Mol Microbiol       Date:  2011-01-05       Impact factor: 3.501

7.  Extracellular fibrils of pathogenic yeast Cryptococcus gattii are important for ecological niche, murine virulence and human neutrophil interactions.

Authors:  Deborah J Springer; Ping Ren; Ramesh Raina; Yimin Dong; Melissa J Behr; Bruce F McEwen; Samuel S Bowser; William A Samsonoff; Sudha Chaturvedi; Vishnu Chaturvedi
Journal:  PLoS One       Date:  2010-06-07       Impact factor: 3.240

8.  Structural and functional properties of the Trichosporon asahii glucuronoxylomannan.

Authors:  Fernanda L Fonseca; Susana Frases; Arturo Casadevall; Olga Fischman-Gompertz; Leonardo Nimrichter; Marcio L Rodrigues
Journal:  Fungal Genet Biol       Date:  2009-03-12       Impact factor: 3.495

9.  Cryptococcus neoformans glucuronoxylomannan fractions of different molecular masses are functionally distinct.

Authors:  Priscila C Albuquerque; Fernanda L Fonseca; Fabianno F Dutra; Marcelo T Bozza; Susana Frases; Arturo Casadevall; Marcio L Rodrigues
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

10.  Role for chitin and chitooligomers in the capsular architecture of Cryptococcus neoformans.

Authors:  Fernanda L Fonseca; Leonardo Nimrichter; Radames J B Cordero; Susana Frases; Jessica Rodrigues; David L Goldman; Ryszard Andruszkiewicz; Slawomir Milewski; Luiz R Travassos; Arturo Casadevall; Marcio L Rodrigues
Journal:  Eukaryot Cell       Date:  2009-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.